Literature DB >> 22548905

Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery research.

Gary Gilmour1, Alexander Arguello, Andrea Bari, Verity J Brown, Cameron Carter, Stan B Floresco, David J Jentsch, David S Tait, Jared W Young, Trevor W Robbins.   

Abstract

Executive control is an aspect of cognitive function known to be impaired in schizophrenia. Previous meetings of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) group have more precisely defined executive control in terms of two constructs: "rule generation and selection", and "dynamic adjustments of control". Next, human cognitive tasks that may effectively measure performance with regard to these constructs were identified to be developed into practical and reliable measures for use in treatment development. The aim of this round of CNTRICS meetings was to define animal paradigms that have sufficient promise to warrant further investigation for their utility in measuring these constructs. Accordingly, "reversal learning" and the "attentional set-shifting task" were nominated to assess the construct of rule generation and selection, and the "stop signal task" for the construct of dynamic adjustments of control. These tasks are described in more detail here, with a particular focus on their utility for drug discovery efforts. Presently, each assay has strengths and weaknesses with regard to this point and increased emphasis on improving practical aspects of testing, understanding predictive validity, and defining biomarkers of performance represent important objectives in attaining confidence in translational validity here. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognition; Cognitive neuroscience; Drug discovery; Executive control; Reversal; Schizophrenia; Set-shifting; Stop signal

Mesh:

Year:  2012        PMID: 22548905     DOI: 10.1016/j.neubiorev.2012.04.006

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  30 in total

Review 1.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

2.  Impaired cognitive flexibility following NMDAR-GluN2B deletion is associated with altered orbitofrontal-striatal function.

Authors:  Kristin Marquardt; Megan Josey; Johnny A Kenton; James F Cavanagh; Andrew Holmes; Jonathan L Brigman
Journal:  Neuroscience       Date:  2019-02-08       Impact factor: 3.590

Review 3.  Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

Authors:  Cassandra J Hatzipantelis; Monica Langiu; Teresa H Vandekolk; Tracie L Pierce; Jess Nithianantharajah; Gregory D Stewart; Christopher J Langmead
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-28

4.  Differential effects of d- and l-enantiomers of govadine on distinct forms of cognitive flexibility and a comparison with dopaminergic drugs.

Authors:  Gemma L Dalton; Stan B Floresco; Anthony G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2021-01-11       Impact factor: 4.530

5.  Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats.

Authors:  Susan B Powell; Asma Khan; Jared W Young; Christine N Scott; Mahalah R Buell; Sorana Caldwell; Elisa Tsan; Loek A W de Jong; Dean T Acheson; Jacinta Lucero; Mark A Geyer; M Margarita Behrens
Journal:  Dev Neurosci       Date:  2015-05-23       Impact factor: 2.984

6.  Dissociable effects of NR2A and NR2B NMDA receptor antagonism on cognitive flexibility but not pattern separation.

Authors:  Gaurav Kumar; Joseph Olley; Thomas Steckler; John Talpos
Journal:  Psychopharmacology (Berl)       Date:  2015-07-18       Impact factor: 4.530

7.  Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity.

Authors:  Joshua D Vardigan; Henry S Lange; Spencer J Tye; Steven V Fox; Sean M Smith; Jason M Uslaner
Journal:  Psychopharmacology (Berl)       Date:  2016-04-27       Impact factor: 4.530

8.  Behavioral assessment of acute inhibition of system xc (-) in rats.

Authors:  Victoria Lutgen; Jon Resch; Krista Qualmann; Nicholas J Raddatz; Cristina Panhans; Ellen M Olander; Linghai Kong; SuJean Choi; John R Mantsch; David A Baker
Journal:  Psychopharmacology (Berl)       Date:  2014-05-15       Impact factor: 4.530

Review 9.  Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity.

Authors:  Z A Cope; S B Powell; J W Young
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

10.  Reversal learning and experimenter-administered chronic intermittent ethanol exposure in male rats.

Authors:  Kimberly A Badanich; Mackinzie E Fakih; Tatyana S Gurina; Emalie K Roy; Jessica L Hoffman; Adriana R Uruena-Agnes; Cheryl L Kirstein
Journal:  Psychopharmacology (Berl)       Date:  2016-08-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.